Gilbert F. Amelio's most recent trade in Galectin Therapeutics Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 24, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc | Gilbert Amelio F. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Galectin Therapeutics Inc | Gilbert F. Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
Galectin Therapeutics Inc | Gilbert F. Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
Galectin Therapeutics Inc | Gilbert F. Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 70,000 | 70,000 | - | - | Stock option (right to buy) | |
Galectin Therapeutics Inc | Gilbert F. Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 40,000 | 40,000 | - | - | Stock option (right to buy) | |
Galectin Therapeutics Inc | Gilbert F. Amelio | Director | Sale of securities on an exchange or to another person at price $ 2.17 per share. | 11 Jan 2021 | 60,000 | 60,614 (0%) | 0% | 2.2 | 130,200 | Common Stock |